Understanding the Hierarchy of Protein Journals: How AI Protein Research is Changing Academic Publishing Rules?

Proteomics is the core research foundation for precision medicine, innovative drugs, synthetic biology, and industrial biotechnology, and professional journals are the key platforms for confirming achievements, disseminating technology, and transforming research into industry. From structural analysis to AI-based de novo design, from functional mechanisms to industrial validation, groundbreaking progress in the protein field has always relied on academic journals for dissemination. This article systematically reviews the classification and industry value of protein journals and, combined with the latest advances in AI-driven protein research, analyzes the evolving trends in the academic publishing ecosystem.

I. What are protein journals? Core positioning and research scope

Protein journals are specialized academic publications that focus on proteomics, macromolecular structure, protein functional modification, expression and purification, action mechanisms, and industrial applications. Peer review is the core quality control mechanism. They publish original research, reviews, and technical method papers across the intersections of life sciences, bioengineering, biomedicine, and synthetic biology, forming the core infrastructure of the macromolecule academic system.

Compared to general biology journals, protein-specific journals are more focused in their subfields, have more specialized reviewers, and their content can be divided into three main sections:

1. Basic theoretical research: Protein sequence analysis, 3D structure analysis, protein interactions, cellular metabolism regulation, multi-omics big data mining;

2. Technical and method innovations: New expression and purification techniques, site-directed mutagenesis, high-throughput screening, AI protein structure prediction and de novo design, new mass spec detection technologies;

3. Industrial application research: Performance optimization of therapeutic antibodies, industrial catalytic enzymes, diagnostic proteins, genome editing tool proteins, pilot-scale and industrial validation.

The launch of Molecular & Cellular Proteomics (MCP) in 2002 marked the birth of the world’s first journal dedicated to proteomics. After more than 20 years of development, a complete journal matrix covering basic research, technology, and industry has now formed, creating an academic dissemination channel from fundamental science to industrial implementation.

II. Analysis of mainstream protein journal classification and industry recognition

 The three tiers of journals in the field of protein research

In the industry, core journals in the protein field are usually divided into three tiers based on journal category, impact factor, and indexing scope: top-tier comprehensive journals, specialized authoritative journals, and application-oriented journals. This categorization accommodates different research levels and publication needs. The impact factor data below is based on the latest JCR data released by Clarivate on June 17, 2026 (i.e., the 2025 journal impact factor); the Chinese Academy of Sciences (CAS) zone information refers to the 2025 zoning table—starting in 2026, the CAS Literature and Information Center officially announced it will no longer update or release journal zoning tables, so the 2025 version is the official last edition. After the discontinuation, many universities in China adopt the “nearest previous principle” to continue using the 2025 data, meaning the reference weight for evaluation systems like JCR zones and emerging zones has increased accordingly.

1. Top-tier Comprehensive Journals (Industry Leads)

These journals are the top-tier publications in life sciences, extensively covering large-scale proteomics cohort studies, disruptive technological innovations, and major disease mechanism research. Their recognition spans both academia and industry. According to 2026 JCR data, Nature has an impact factor of 56.1, Science 47.3, and Cell 45.1—the three leading journals remain at the top of the academic field.

For associated sub-journals, Nature Communications has an impact factor of 18.1, and the domestic journal Cell Research reaches 31.1. Both mainly publish breakthrough studies based on high-throughput proteomics and multi-omics analyses, particularly valuing original work with clinical translation or industrial application potential. In structural biology, Nature Structural & Molecular Biology (IF approximately 25–30) is also a major top choice for protein research submissions.

2. Specialized Authoritative Protein Journals (Core of the Field)

Focused on protein and macromolecular research, these journals are the core platform for basic research and technological innovation in the field, with highly professional peer review and high recognition of published work.

- Molecular & Cellular Proteomics (MCP): A well-established authoritative journal in proteomics, focusing on proteomics methods and cellular protein mechanism research. The 2026 impact factor is 6.3, JCR Q1, CAS Biology Zone 2 (2025 version).

- Protein & Cell: A China-hosted international authoritative journal, fully open access, covering protein basic research and biomedical cross-innovation. The 2026 impact factor is 18.2, JCR Q1, Top 1 in CAS Biology Zone (2025 version), and is a frequently chosen high-quality journal for domestic researchers.

- Journal of Biological Chemistry (JBC): A classic biochemistry and molecular biology journal, with a 2026 impact factor of 4.1. It publishes a large volume of papers with stable peer review, serving as a mainstream choice for research on protein function and mechanisms.

3. Application-Oriented SCI Journals (Suitable for Industrialization Research)

Represented by the International Journal of Biological Macromolecules (IJBM) and The Protein Journal, these journals focus on practical research such as protein application technologies, structural modification, and functional validation, making them suitable for publishing industrialized results like industrial proteins, therapeutic proteins, and enzyme modifications.

- IJBM: 2026 impact factor of 8.7, JCR Q1, Chinese Academy of Sciences Biology Category 2 (2025 edition), covers research on the structure and function of biological macromolecules such as proteins, enzymes, and polysaccharides;

- The Protein Journal: impact factor around 1.9, Chinese Academy of Sciences Biology Category 4 (2025 edition), generally stable with controllable review cycles, making it a cost-effective choice for industrial research teams.

III. Core Industry Value of Protein Journals: The Key Link Between Research and Industry

In today’s fast-growing bioindustry, protein journals have long gone beyond being just a "platform for academic publications". They have become core infrastructure that drives technological iteration, standardizes industry regulations, and empowers industrial innovation. Their core value can be seen in three areas.

First, solidifying the academic innovation system. The strict peer review process screens and validates high-quality research, avoiding redundant studies and false data, and establishes unified academic standards for cutting-edge fields such as protein structure analysis, AI protein design, and functional modification, promoting continuous technological advancement.

Second, breaking down barriers in industry-university-research collaboration. The numerous application-oriented studies published in these journals provide theoretical support and technical references for industrial enzyme optimization, innovative drug target development, in vitro diagnostic protein research, and synthetic biology applications. For example, enzyme modification studies published in journals like Biotechnology and Bioengineering are often directly used by companies as technical guidance for process optimization, significantly shortening the path from basic research to industrial implementation.

Finally, establishing industry value consensus. High-level journal papers not only serve as core evidence of a researcher’s academic ability but also function as important endorsements of a biotech company’s technical strength and R&D innovation capacity, providing authoritative support for project applications, technical collaborations, and research commercialization.

IV. What Changes Are Happening in Protein Journals in the AI Era?

AI is not only revolutionizing protein research methods but also completely transforming the whole process of paper production, review, and dissemination. Three major industry trends now align with global standardized norms:

1. Normalization of preprints to quickly establish research priority

Traditional journals usually take 6–12 months from submission to official publication, while AI protein research evolves much faster. Preprint platforms have become an important channel for rapidly sharing results. Researchers can upload their manuscripts to preprint platforms like bioRxiv, arXiv, or ChinaXiv simultaneously with journal submission. The preprint’s timestamp can serve as preliminary proof of completion, but the official priority of academic results still depends on legally recognized points, such as the journal publication date or patent filing date, while also receiving early feedback from global peers. Major AI protein innovations in the field generally follow a dual-channel dissemination model: “preprint first, journal publication later.”

2. AI-assisted end-to-end publishing, with transparent ethical disclosure standards

AI deeply integrates into all stages of paper preparation: writing, figure generation, initial journal check, and reviewer recommendation. Researchers use AI for text polishing, professional translation, and experiment data organization; journal editorial offices use AI for initial screening, plagiarism checks, and academic image anomaly detection. According to COPE (Committee on Publication Ethics) and the International Association of Scientific, Technical & Medical Publishers (STM) general principles for AI tool use, and following the 2025–2026 AI publishing guidelines updated by leading publishers such as Frontiers and Nature Portfolio, all AI-assisted text, images, and analyses must be fully disclosed in the methods section or a dedicated AI disclosure statement. Authors remain fully responsible for the scientific accuracy and authenticity of the original data.

3. From single-paper publication to research data asset accumulation

Traditional journals focus on the text and figures, treating raw protein sequences, mass spectrometry data, and 3D structural data as supplementary material. Today, major protein journals globally require authors to upload raw data to public databases, strictly following the FAIR principles (Findable, Accessible, Interoperable, Reusable). Standardized open-source protein annotation data can feed back into AI protein design model training, creating a positive cycle: “paper publication → open data → AI model iteration → new research output.”

Attachment: Suggested submission pathways for AI protein research

AI protein research combines computational methodology with biological experiments, so journal selection should match the focus of your study:

- Pure AI methodological innovation (like new protein structure prediction algorithms or de novo design frameworks): consider methodology journals such as Nature Methods, Nature Biotechnology, Cell Reports Methods, etc.;

- AI design with experimental validation (with clear functional/activity data): suitable for general biology journals like Protein & Cell, Nature Communications, Nature Chemical Biology, etc.;

- Industrial enzyme/drug protein application and modification: fits application-oriented journals like IJBM, Biotechnology and Bioengineering, Protein Science, etc.;

- Computational structural biology: could go to Structure, Nature Computational Science, PLOS Computational Biology.

V. Coordination between AI protein R&D toolchains and journal publication.

 A closed-loop workflow from AI-driven protein research and development to journal publication

AI technology has shortened the protein engineering R&D cycle from several years to just a few months, while its interdisciplinary nature has expanded channels for submitting results. Researchers’ demand for integrated 'AI design + data processing + paper assistance' tools keeps rising. Domestic full-chain tools, represented by Shanghai Matwings Technology’s self-developed MatwingsVenus™ (Xiaowu™), are exploring a complete closed-loop solution from protein R&D to journal submission.

The core value of these platforms lies in precisely meeting the end-to-end requirements for journal publication: with a self-developed protein design large model as the foundation, integrating professional protein design tools and large-scale annotated protein databases, and supporting research assistance modules—from targeted literature research (helping understand target journal submission preferences), standardized data output (creating datasets following FAIR principles, meeting journal data archiving requirements), to compliant AI tool disclosure (assisting in generating AI usage statements that meet publishing ethics standards)—forming integrated support covering the whole process from R&D to submission.

Compared to overseas tools, domestic platforms have differentiated advantages in data compliance and local adaptation: the underlying models, algorithms, and data storage are all independently developed, so primary research data doesn’t need to be stored abroad, aligning with the data compliance management requirements of local universities and bio-pharma companies; meanwhile, these platforms can connect with automated wet lab platforms to automatically archive experimental raw data, reducing the tedious work of organizing attachments and verifying data traceability during journal submission.

According to public reports, Matwings Technology has completed over 40 protein engineering projects, with more than 10 industrialized, covering areas such as the circular economy (e.g., designing highly efficient plastic-degrading enzymes within six months), innovative drugs (e.g., de novo design validation of immune-regulating receptor targets), health (e.g., enzymatic lactulose), in vitro diagnostics, food and beverage, and bioenergy.

VI. Conclusion: Journal Formats Evolve, But the Essence of Scientific Truth Remains

Over decades, protein science publishing has continuously evolved: print journals have fully shifted to online open access, single peer review has expanded into a dual-track system with preprints first, and pure text papers now release alongside open-source data assets. Yet, the core role of journals—documenting scientific exploration, sharing academic consensus, and verifying scientific truth—has never changed.

Protein science still faces many frontier challenges: mechanisms of protein folding regulation, protein phase separation’s role in cellular function, fully de novo designed functional proteins, and more. Every breakthrough relies on professional journals for industry-wide dissemination and academic validation.

In the new era of AI-driven biomanufacturing, journals are no longer the sole standard for evaluating research outcomes, but they remain the core arena for the scientific community to consolidate knowledge and establish innovation value. With AI-assisted peer review, open research data, and well-developed domestic integrated research tools, protein science publishing is moving toward a more efficient, open, and intelligent ecosystem, continually supporting long-term innovation in biopharma, green industrial enzymes, and synthetic biology.